
Except for its recent jump, Moderna stock has been at the lows. The remarkable Q1 2022 performance may give Moderna a boost and help its stock to rebound.
Moderna specializes in drug discovery and drug development based on messenger RNA.
Moderna, Inc. is a Cambridge, Massachusetts-based biotechnology company that is focused on drug discovery and drug development based on messenger RNA (mRNA). The company creates synthetic mRNA that can be injected into patients to help them create their own therapies.
Except for its recent jump, Moderna stock has been at the lows. The remarkable Q1 2022 performance may give Moderna a boost and help its stock to rebound.
Roche posted good numbers for Q1 2022 and expects a stable outlook for the rest of the year despite waning Covid medicine sales.
Despite the hike in interest rate by 25 basis points back in March, inflation is still not well tamed in the US and the stock market is pricing in this reality.